Omnicell Profit Margin 2006-2019 | OMCL

Current and historical gross margin, operating margin and net profit margin for Omnicell (OMCL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Omnicell net profit margin as of September 30, 2019 is 6.28%.
Omnicell Annual Profit Margins
Omnicell Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.604B $0.787B
Omnicell, Inc. is a leading provider of medication and supply management automation, analytics software, and medication adherence solutions for healthcare organizations. It works with healthcare providers to drive operational efficiency by removing tedious tasks and waste. Regardless of distribution model, their solutions automate manual processes-including ordering, receiving, stocking, and picking medications. At Omnicell, delivering their technology is just the beginning. Omnicell Inc., is also committed to delivering the best customer experience. To ensure their customers gain the most utility from their Omnicell systems, the Company offers a comprehensive training and education program and first-rate customer support.
Stock Name Country Market Cap PE Ratio
Cerner (CERN) United States $23.827B 32.84
Syneos Health (SYNH) United States $6.642B 23.35
Livongo Health (LVGO) United States $2.783B 0.00
HMS Holdings Corp (HMSY) United States $2.531B 27.89
IRHYTHM TECH (IRTC) United States $2.263B 0.00
Inspire Medical Systems (INSP) United States $1.984B 0.00
Invitae (NVTA) United States $1.895B 0.00
Allscripts Healthcare Solutions (MDRX) United States $1.575B 19.02
Tabula Rasa Healthcare (TRHC) United States $1.219B 0.00
NEXTGEN HEALTHCARE, INC (NXGN) United States $1.040B 27.90
Axonics Modulation Technologies (AXNX) United States $0.901B 0.00
111 (YI) China $0.541B 0.00
Computer Programs And Systems (CPSI) United States $0.401B 21.51
Centogene (CNTG) Germany $0.271B 0.00
FULGENT GENETIC (FLGT) United States $0.256B 0.00
ECMOHO (MOHO) China $0.246B 0.00
Predictive Technology (PRED) United States $0.239B 0.00
NantHealth (NH) United States $0.159B 0.00
Strata Skin Sciences (SSKN) United States $0.072B 0.00
MDxhealth SA (MXDHF) Belgium $0.066B 0.00
Motus GI Holdings (MOTS) United States $0.066B 0.00
Medical Transcription Billing (MTBC) United States $0.058B 0.00
Streamline Health Solutions (STRM) United States $0.039B 0.00
Transgenomic (PRPO) United States $0.017B 0.00
Digirad (DRAD) United States $0.006B 0.00